Literature DB >> 26976888

Epidemiology of Domestically Acquired Amebiasis in Japan, 2000-2013.

Masahiro Ishikane1, Yuzo Arima2, Atsuhiro Kanayama1, Takuri Takahashi1, Takuya Yamagishi1, Yuichiro Yahata1, Tamano Matsui1, Tomimasa Sunagawa1, Tomoyoshi Nozaki1, Kazunori Oishi1.   

Abstract

Notifications of amebiasis have been increasing in Japan. Using national surveillance data during 2000-2013, reported cases of amebiasis were analyzed. A case of amebiasis was defined as laboratory-confirmed Entamoeba histolytica infection, regardless of presence of symptoms. We described temporal trends and analyzed correlates of asymptomatic versus symptomatic cases based on odds ratios (ORs) and 95% confidence intervals (CIs) using logistic regression. Of 9,946 cases reported during 2000-2013, 7,403 were domestic cases. During this period, the proportion of domestic cases increased from 63% to 85%. Among male cases, majority were middle aged, and from 2008, the number of cases attributed to heterosexual contact surpassed that of homosexual contact. During 2010-2013, increase in notifications was associated with asymptomatic cases, colonoscopy diagnosis, and males with unknown or heterosexual route of infection. Among males, colonoscopy (OR = 31.5; 95% CI = 14.0-71.0) and cases with unknown route of infection, relative to homosexual contact (OR = 2.2; 95% CI = 1.3-3.9), were associated with asymptomatic infections in multivariate analysis. Although the recent rise may have been due to enhanced detection by colonoscopy or reporting, the large number of asymptomatic cases, with reportedly unknown or heterosexual route of infection, has led to a better understanding of amebiasis in Japan and highlights the potential public health concern. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Year:  2016        PMID: 26976888      PMCID: PMC4856595          DOI: 10.4269/ajtmh.15-0560

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  23 in total

1.  A school waterborne outbreak involving both Shigella sonnei and Entamoeba histolytica.

Authors:  K T Chen; C J Chen; J P Chiu
Journal:  J Environ Health       Date:  2001-11       Impact factor: 1.179

2.  Differences in misreporting of sexual behavior over time: implications for HIV trials.

Authors:  Maria F Gallo; Lee Warner; Marcia M Hobbs; Denise J Jamieson; Tina Hylton-Kong; Markus J Steiner
Journal:  Sex Transm Dis       Date:  2015-03       Impact factor: 2.830

3.  Pathogenic zymodemes of Entamoeba histolytica in Japanese male homosexual population.

Authors:  T Nozaki; S R Motta; T Takeuchi; S Kobayashi; P G Sargeaunt
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 Jul-Aug       Impact factor: 2.184

4.  Endoscopic findings and lesion distribution in amebic colitis.

Authors:  Noriyuki Horiki; Keiichi Furukawa; Takashi Kitade; Takashi Sakuno; Masaki Katsurahara; Tetsuro Harada; Shunsuke Tano; Reiko Yamada; Yasuhiko Hamada; Hiroyuki Inoue; Kyosuke Tanaka; Esteban C Gabazza; Naoki Ishii; Katsuyuki Fukuda; Fumio Omata; Yoshiyuki Fujita; Hiroshi Tachibana; Yoshiyuki Takei
Journal:  J Infect Chemother       Date:  2015-02-12       Impact factor: 2.211

5.  Amebic colitis in asymptomatic subjects with positive fecal occult blood test results: clinical features different from symptomatic cases.

Authors:  Makoto Okamoto; Takao Kawabe; Ken Ohata; Gouichi Togo; Tetsuya Hada; Tetsurou Katamoto; Masataka Tanno; Masayuki Matsumura; Yutaka Yamaji; Hirotsugu Watabe; Tsuneo Ikenoue; Haruhiko Yoshida; Masao Omata
Journal:  Am J Trop Med Hyg       Date:  2005-11       Impact factor: 2.345

6.  Present characteristics of symptomatic Entamoeba histolytica infection in the big cities of Japan.

Authors:  K Ohnishi; Y Kato; A Imamura; M Fukayama; T Tsunoda; Y Sakaue; M Sakamoto; H Sagara
Journal:  Epidemiol Infect       Date:  2004-01       Impact factor: 2.451

7.  Field study on the distribution of Entamoeba histolytica and Entamoeba dispar in the northern Philippines as detected by the polymerase chain reaction.

Authors:  W L Rivera; H Tachibana; H Kanbara
Journal:  Am J Trop Med Hyg       Date:  1998-12       Impact factor: 2.345

8.  Entamoeba histolytica infection in men who have sex with men.

Authors:  Chien-Ching Hung; Sui-Yuan Chang; Dar-Der Ji
Journal:  Lancet Infect Dis       Date:  2012-09       Impact factor: 25.071

9.  Epidemiological features of intestinal infection with Entamoeba histolytica in Taiwan, 2002-2010.

Authors:  Pak-On Leung; Kou-Huang Chen; Kwo-Liang Chen; Yu-Ting Tsai; Shyun-Yeu Liu; Kow-Tong Chen
Journal:  Travel Med Infect Dis       Date:  2014-05-05       Impact factor: 6.211

10.  A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target.

Authors:  Anjan Debnath; Derek Parsonage; Rosa M Andrade; Chen He; Eduardo R Cobo; Ken Hirata; Steven Chen; Guillermina García-Rivera; Esther Orozco; Máximo B Martínez; Shamila S Gunatilleke; Amy M Barrios; Michelle R Arkin; Leslie B Poole; James H McKerrow; Sharon L Reed
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

View more
  9 in total

1.  Underestimated Amoebic Appendicitis among HIV-1-Infected Individuals in Japan.

Authors:  Taiichiro Kobayashi; Koji Watanabe; Hideaki Yano; Yukinori Murata; Toru Igari; Kumiko Nakada-Tsukui; Kenji Yagita; Tomoyoshi Nozaki; Mitsuo Kaku; Kunihisa Tsukada; Hiroyuki Gatanaga; Yoshimi Kikuchi; Shinichi Oka
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

2.  Discovery of Antiamebic Compounds That Inhibit Cysteine Synthase From the Enteric Parasitic Protist Entamoeba histolytica by Screening of Microbial Secondary Metabolites.

Authors:  Mihoko Mori; Satoshi Tsuge; Wataru Fukasawa; Ghulam Jeelani; Kumiko Nakada-Tsukui; Kenichi Nonaka; Atsuko Matsumoto; Satoshi Ōmura; Tomoyoshi Nozaki; Kazuro Shiomi
Journal:  Front Cell Infect Microbiol       Date:  2018-12-05       Impact factor: 5.293

Review 3.  Phosphatidylinositol Kinases and Phosphatases in Entamoeba histolytica.

Authors:  Kumiko Nakada-Tsukui; Natsuki Watanabe; Tomohiko Maehama; Tomoyoshi Nozaki
Journal:  Front Cell Infect Microbiol       Date:  2019-06-06       Impact factor: 5.293

4.  Seroprevalence of Entamoeba histolytica at a voluntary counselling and testing centre in Tokyo: a cross-sectional study.

Authors:  Yasuaki Yanagawa; Mami Nagashima; Hiroyuki Gatanaga; Yoshimi Kikuchi; Shinichi Oka; Keiko Yokoyama; Takayuki Shinkai; Kenji Sadamasu; Koji Watanabe
Journal:  BMJ Open       Date:  2020-02-25       Impact factor: 2.692

5.  Identification of asymptomatic Entamoeba histolytica infection by a serological screening test: A cross-sectional study of an HIV-negative men who have sex with men cohort in Japan.

Authors:  Yasuaki Yanagawa; Rieko Shimogawara; Misao Takano; Takahiro Aoki; Daisuke Mizushima; Hiroyuki Gatanaga; Yoshimi Kikuchi; Shinichi Oka; Kenji Yagita; Koji Watanabe
Journal:  PLoS Negl Trop Dis       Date:  2022-04-25

Review 6.  Utilization of Different Omic Approaches to Unravel Stress Response Mechanisms in the Parasite Entamoeba histolytica.

Authors:  Shruti Nagaraja; Serge Ankri
Journal:  Front Cell Infect Microbiol       Date:  2018-02-08       Impact factor: 5.293

7.  Two cases of endoscopically diagnosed amebic colitis treated with paromomycin monotherapy.

Authors:  Kei Yamamoto; Yasuaki Yanagawa; Shinichi Oka; Koji Watanabe
Journal:  PLoS Negl Trop Dis       Date:  2020-03-19

8.  COP9 signalosome is an essential and druggable parasite target that regulates protein degradation.

Authors:  Swagata Ghosh; Laura Farr; Aditya Singh; Laura-Ann Leaton; Jay Padalia; Debbie-Ann Shirley; David Sullivan; Shannon Moonah
Journal:  PLoS Pathog       Date:  2020-09-22       Impact factor: 6.823

9.  Utility of the Rapid Antigen Detection Test E. histolytica Quik Chek for the Diagnosis of Entamoeba histolytica Infection in Nonendemic Situations.

Authors:  Yasuaki Yanagawa; Rieko Shimogawara; Tomoyuki Endo; Rika Fukushima; Hiroyuki Gatanaga; Kasumi Hayasaka; Yoshimi Kikuchi; Taiichiro Kobayashi; Michiko Koga; Tomohiko Koibuchi; Toshikazu Miyagawa; Ayaka Nagata; Hirotomo Nakata; Shinichi Oka; Risa Otsuka; Kazumi Sakai; Mami Shibuya; Hiroyuki Shingyochi; Etsuko Tsuchihashi; Koji Watanabe; Kenji Yagita
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.